Matthew A. Boehm

640 total citations
7 papers, 289 citations indexed

About

Matthew A. Boehm is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, Matthew A. Boehm has authored 7 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 3 papers in Cognitive Neuroscience and 1 paper in Molecular Biology. Recurrent topics in Matthew A. Boehm's work include Neuroscience and Neuropharmacology Research (3 papers), Photoreceptor and optogenetics research (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Matthew A. Boehm is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Photoreceptor and optogenetics research (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Matthew A. Boehm collaborates with scholars based in United States and Spain. Matthew A. Boehm's co-authors include Juan L. Gomez, Robin M. Lloyd, J. Roxanne Prichard, Michael Michaelides, Jordi Bonaventura, Óscar Solís, Carlos A. Zarate, Yavin Shaham, Ida Fredriksson and Craig J. Thomas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Science Translational Medicine and Molecular Psychiatry.

In The Last Decade

Matthew A. Boehm

7 papers receiving 285 citations

Peers

Countries citing papers authored by Matthew A. Boehm

Since Specialization

Citations

This map shows the geographic impact of Matthew A. Boehm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Boehm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Boehm more than expected).

Fields of papers citing papers by Matthew A. Boehm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Boehm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Boehm. The network helps show where Matthew A. Boehm may publish in the future.

Co-authorship network of co-authors of Matthew A. Boehm

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Boehm. A scholar is included among the top collaborators of Matthew A. Boehm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Boehm. Matthew A. Boehm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Expression of the excitatory opsin ChRERα can be traced longitudinally in rat and nonhuman primate brains with PET imaging 2023 ·Science Translational Medicine ·Jordi Bonaventura, Matthew A. Boehm, Hank P. Jedema, Óscar Solís, Marco Pignatelli, Xiaowei Song, Hanbing Lu, Christopher T. Richie, (unknown), Juan L. Gomez, Sherry Lam, Marisela Morales, Omar A. Gharbawie, Martin G. Pomper, Elliot A. Stein, Charles W. Bradberry, Michael Michaelides	4
2	DREADD-mediated amygdala activation is sufficient to induce anxiety-like responses in young nonhuman primates 2023 ·SHILAP Revista de lepidopterología ·(unknown), Jonathan A. Oler, Patrick H. Roseboom, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bradley T. Christian, Xing Hu, Adriana Galván, Matthew A. Boehm, Michael Michaelides, Ned H. Kalin	4
3	Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability 2021 ·Molecular Psychiatry ·Jordi Bonaventura, Sherry Lam, (unknown), Matthew A. Boehm, Juan L. Gomez, Óscar Solís, Marta Sánchez‐Soto, Patrick J. Morris, Ida Fredriksson, Craig J. Thomas, David R. Sibley, Yavin Shaham, Carlos A. Zarate, Michael Michaelides	178
4	Evidence in primates supporting the use of chemogenetics for the treatment of human refractory neuropsychiatric disorders 2021 ·Molecular Therapy ·Patrick H. Roseboom, (unknown), Jonathan A. Oler, Andrew S. Fox, (unknown), (unknown), (unknown), Juan L. Gomez, Matthew A. Boehm, (unknown), Bradley T. Christian, Michael Michaelides, Ned H. Kalin	22
5	Translational PET applications for brain circuit mapping with transgenic neuromodulation tools 2021 ·Pharmacology Biochemistry and Behavior ·Matthew A. Boehm, Jordi Bonaventura, Juan L. Gomez, Óscar Solís, Elliot A. Stein, Charles W. Bradberry, Michel Michaelides	10
6	18F-labeled radiotracers for in vivo imaging of DREADD with positron emission tomography 2020 ·European Journal of Medicinal Chemistry ·Feng Hu, Patrick J. Morris, Jordi Bonaventura, Hong Fan, William B. Mathews, Daniel P. Holt, Sherry Lam, Matthew A. Boehm, Robert F. Dannals, Martin G. Pomper, Michel Michaelides, Andrew G. Horti	6
7	Depression, anxiety, and tobacco use: Overlapping impediments to sleep in a national sample of college students 2016 ·Journal of American College Health ·Matthew A. Boehm, (unknown), Robin M. Lloyd, J. Roxanne Prichard	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact